Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2006, p. 2801-2807, Vol. 44, No. 8
0095-1137/06/$08.00+0 doi:10.1128/JCM.00180-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Center for International Health, University of Bergen, Bergen, Norway,1 Department of Microbiology and Immunology, Muhimbili University College of Health Sciences, Dar Es Salaam, Tanzania,2 Department of Dermatology, Haukeland University Hospital and University of Bergen, Bergen, Norway,3 MRC Virology Unit, Church Street, Glasgow, United Kingdom,4 Departments of Clinical Virology and Bacteriology, Göteborg University, Göteborg, Sweden,5 Department of Medicine, Haukeland University Hospital and University of Bergen, Bergen, Norway,6 Department of Microbiology and Immunology, The Gade Institute, Haukeland University Hospital, Bergen, Norway7
Received 27 January 2006/ Returned for modification 13 March 2006/ Accepted 14 May 2006
Herpes simplex virus type 1 (HSV-1) is transmitted by close contact, both sexual and nonsexual, and infections are acquired during childhood and adolescence. Herpes simplex virus type 2 (HSV-2), however, is thought to be transmitted mainly by sexual contact. Most HSV-2 infections are consequently expected to occur after the onset of sexual activity. Recent reports indicate an increasing prevalence of HSV-2 on the African continent, but most studies have been performed on adult cohorts. In the present study, we collected sera from Tanzanian children and young persons from 1 to 20 years old, with at least 100 individuals in each age group. Antibodies against HSV-1 and HSV-2 were detected by an in-house Western blot method which was shown to perform well in comparison with a commercial Western blot assay. Type-specific antibodies were also analyzed by two noncommercial enzyme-linked immunosorbent assay methods based upon the antigenicities of branched synthetic oligopeptides corresponding to epitopes in glycoprotein G of HSV-1 or HSV-2. The prevalence of HSV-1 antibodies increased gradually from 73% for the age group of 1 to 4 years to 92% for the age group of 17 to 20 years. The prevalence of HSV-2 antibodies was unexpectedly high, as 15% of the children were infected by the age of 8 years, with the incidence increasing gradually to 40% in the age group of 17 to 20 years. The reason for this unexpectedly high frequency is not clear but could suggest that nonsexual transmission of HSV-2 is more common than previously thought. There was no statistically significant association between seropositivities for HSV-2 and human immunodeficiency virus.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|